EDN1 and kidney disorder: Quantitively understanding the physiological effects of ET-1 and ET-1 antagonism in normal subjects is a first step toward better understanding its role in cardiovascular and renal disease, and both the beneficial effects and deleterious fluid retention in previous clinical studies of ETA antagonists.